A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF EPALRESTAT (ONO-2235) IN PATIENTS WITH DIABETIC NEUROPATHY

被引：20

作者：

GOTO, Y ^{[1
]}

HOTTA, N ^{[1
]}

SHIGETA, Y ^{[1
]}

SAKAMOTO, N ^{[1
]}

KITO, S ^{[1
]}

MATSUOKA, K ^{[1
]}

TAKAHASHI, A ^{[1
]}

KIKKAWA, R ^{[1
]}

SAKUMA, A ^{[1
]}

机构：

[1] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 3,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN

来源：

DIABETIC MEDICINE | 1993年 / 10卷 / 05期

关键词：

ALDOSE REDUCTASE INHIBITOR; CLINICAL TRIALS; DIABETIC NEUROPATHY; EPALRESTAT; HEMOGLOBIN A1C; NERVE CONDUCTION VELOCITY;

D O I：

10.1111/j.1464-5491.1993.tb00197.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S39 / S43

页数：5

共 17 条

[1]

Gabbay KH., Hyperglycemia, polyol metabolism and complications of diabetes mellitus, Ann Rev Med, 26, pp. 521-535, (1975)

[2]

Greene DA, Lattimer SA, Ulbrecht J., Et al., Glucose‐induced alterations in nerve metabolism: Current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy, Diabets Care, 8, pp. 290-299, (1985)

[3]

Greene DA, Lattimer SA., Altered myo‐inositol metabolism in diabetic nerve, Diabetic Neuropathy, pp. 289-298, (1987)

[4]

Dvornik D., Aldose Reductase Inhibition: An Approach to the Prevention of Diabetic Complications, (1987)

[5]

Hotta N., Sakamoto N., Aldose reductase inhibitors, The Diabetes Annual/5, pp. 330-361, (1990)

[6]

Jaspan JB, Maselli R., Herold K., Et al., Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: Relief of pain and improved somatic and autonomic nerve function, Lancet, 11, pp. 758-762, (1983)

[7]

Judzewitsch RG, Jaspan JB, Polonsky KS, Et al., Aldose reductase inhibitor improves nerve conduction velocity in diabetic patients, N Engl J Med, 308, pp. 119-125, (1983)

[8]

Goto Y., Oikawa N., Akanuma Y., Et al., Clinical study of a new aldose reductase inhibitor (ONO‐2235) on diabetic neuropathy: Clinical results with 10 institutes in Japan, J Japan Diab Soc, 28, pp. 89-99, (1985)

[9]

Goto Y., Shigeta Y., Sakamoto N., Et al., Clinical evaluation of an aldose reductase inhibitor, ONO‐2235 on diabetic neuropathy

[10]

A double‐blind comparative study, Gendai Iryo, 18, pp. 449-466, (1986)

← 1 2 →